Know Cancer

or
forgot password

Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer


N/A
18 Years
80 Years
Open (Enrolling)
Both
Sentinel Lymph Node Biopsy, Colon Cancer

Thank you

Trial Information

Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer


Inclusion Criteria:



- Stage I - III colon cancer patients

Exclusion Criteria:

- cancer located at the low rectum which were located within 10 cm of the dentate,
recurrent or metastatic colon carcinoma, adjacent organ invasion tumor, prior
chemotherapy or radiation, cancer with intestinal obstruction, past intestinal
surgery

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)

Outcome Measure:

Accuracy & sensitivity of sentinel lymph node mapping

Outcome Time Frame:

After confirmed pathological report

Safety Issue:

No

Authority:

Korea: Food and Drug Administration

Study ID:

caugs_01

NCT ID:

NCT00654342

Start Date:

October 2007

Completion Date:

Related Keywords:

  • Sentinel Lymph Node Biopsy
  • Colon Cancer
  • Sentinel lymph node-colon cancer
  • Colonic Neoplasms

Name

Location